Media centre
Press releases
25/11/2003
Fully underwritten Placing and Open Offer to raise £15.2 million
25 November 2003, London UK: Antisoma plc (London Stock Exchange: ASM), the UK biopharmaceutical company specialising in the development of anti-cancer drugs, today announces that it proposes to raise £15.2 million (£14.0 million net of expenses) by means of a Placing and Open Offer. A prospectus published by the Company and containing details of the Placing and Open Offer (the "Prospectus") is expected to be posted to Shareholders today together with Application Forms in respect of the Open Offer.
Highlights are as follows:- Placing of 38,010,941 New Shares at 40 pence per share to raise
£15.2 million (£14.0 million net of
expenses);
- Open Offer to Qualifying Shareholders on the basis of 1 New
Share for every 6 Ordinary Shares at 40 pence per share;
and
- Placing and Open Offer fully underwritten by Nomura.
Glyn Edwards, Chief Executive Officer of Antisoma,
commented:
"This fundraising will lead to a significant enhancement of our
pipeline by enabling us to acquire new clinical products and to
pursue more ambitious development plans for some of our key
established programmes."
Enquiries:
| Antisoma plc | ||
| Glyn Edwards, Chief Executive Officer | ||
| Raymond Spencer, Chief Financial Officer | +44 (0)20 8799 8200 | |
| Nomura International plc | ||
| Dave Rasouly | ||
| John Milad | +44 (0)20 7521 2000 | |
| Financial Dynamics: | ||
| Ben Atwell | +44 (0)20 7831 3113 | |
| Sarah MacLeod |
|
This page includes links to documents in Portable Document File (PDF) format. To read PDF documents you may need to download the free Adobe Acrobat Reader. For PDF accessibility help, visit Access Adobe. These links will open in a new browser window. |
Back to top